APA
TTPH

American Portfolios Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

American Portfolios Advisors’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50
Closed -$1.34K – 2806
2019
Q1 		$1.34K Hold
50
– – ﹤0.01% 2441
2018
Q4 		$1.13K Hold
50
– – ﹤0.01% 2242
2018
Q3 		$2.76K Hold
50
– – ﹤0.01% 2175
2018
Q2 		$3.57K Hold
50
– – ﹤0.01% 2084
2018
Q1 		$3.07K Hold
50
– – ﹤0.01% 2014
2017
Q4 		$6.3K Buy
+50
New +$6.4K ﹤0.01% 1749

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

American Portfolios Advisors's TTPH Position: Q2 2019 in Review

American Portfolios Advisors sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 50 shares — an estimated $1.34K sold.

American Portfolios Advisors first reported a position in TTPH in Q4 2017 and held it in 6 quarters. The position peaked at $6.3K in Q4 2017. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • American Portfolios Advisors reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 50 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1.34K.
  • American Portfolios Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2017 and held it in 6 quarters.
  • American Portfolios Advisors's Tetraphase Pharmaceuticals, Inc. position peaked at $6.3K in Q4 2017.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on American Portfolios Advisors's 13F filing for Q2 2019, filed 24 Mar 2023.